Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Caroline M. A. van den Bosch"'
Autor:
Marlies E J L Hulscher, Reinier Akkermans, Jan M. Prins, Caroline M. A. van den Bosch, Jan Wille, Suzanne E. Geerlings
Publikováno v:
Journal of antimicrobial chemotherapy, 72(3), 923-932. Oxford University Press
Journal of Antimicrobial Chemotherapy, 72, 923-932
Journal of Antimicrobial Chemotherapy, 72, 3, pp. 923-932
Journal of Antimicrobial Chemotherapy, 72, 923-932
Journal of Antimicrobial Chemotherapy, 72, 3, pp. 923-932
Item does not contain fulltext Objectives: To define appropriate antibiotic use in hospitalized adults treated for a bacterial infection, we previously developed and validated a set of six generic quality indicators (QIs) covering all steps in the pr
Autor:
Stephanie Natsch, J.M. Prins, Caroline M. A. van den Bosch, Emelie C Schuts, Bart Jan Kullberg, Martha B. Adams, Fre Sebens, Maurine A. Leverstein-van Hall, Richard H. Drew, Inge C. Gyssens
Publikováno v:
European Journal of Clinical Pharmacology, 72, 249-52
European journal of clinical pharmacology, 72(2), 249-252. Springer Verlag
European Journal of Clinical Pharmacology, 72, 2, pp. 249-52
European journal of clinical pharmacology, 72(2), 249-252. Springer Verlag
European Journal of Clinical Pharmacology, 72, 2, pp. 249-52
[Schuts, Emelie C.; van den Bosch, Caroline M.; Prins, Jan M.] Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Internal Med, Div Infect Dis, Room F4-217,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands. [Gyssens, Inge C.; Kullberg, Bart-Jan]
Autor:
Jan M. Prins, Caroline M. A. van den Bosch, Stephanie Natsch, Marlies E J L Hulscher, Suzanne E. Geerlings
Publikováno v:
Clinical Infectious Diseases, 60, 281-91
Clinical Infectious Diseases, 60, 2, pp. 281-91
Clinical infectious diseases, 60(2), 281-291. Oxford University Press
Clinical Infectious Diseases, 60, 2, pp. 281-91
Clinical infectious diseases, 60(2), 281-291. Oxford University Press
Item does not contain fulltext BACKGROUND: An important requirement for an effective antibiotic stewardship program is the ability to measure appropriateness of antibiotic use. The aim of this study was to develop quality indicators (QIs) that can be
Autor:
Caroline M A, van den Bosch, Marlies E J L, Hulscher, Jan, Wille, Stephanie, Natsch, Birgit H B, van Benthem, Jan M, Prins, Suzanne E, Geerlings
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 155(33)
As in other countries, the growing resistance to antimicrobial drugs is also taking place in the Netherlands; the primary cause being the total consumption of antibiotics. Given the steady decline in the discovery of new antimicrobials, better use of